Explore insights into early-phase drug development with expert advice, case studies, and practical considerations for pharmaceutical and biotechnology companies.
Issue 42 — Managing the Complexities of Glucagon -like Peptide-1 Receptor Agonist Drug Development
49 mins • Nov 15, 2024
Charts
This show is not currently ranked in any charts.
Recent Episodes
Nov 15, 2024
Issue 42 — Managing the Complexities of Glucagon -like Peptide-1 Receptor Agonist Drug Development
49 mins
Sep 20, 2024
Issue 41 — Immunomodulation Assessments for Clinical Trials
31 mins
Sep 20, 2024
Issue 40 — Analytical Testing: Maximizing API Bioavailability
27 mins
May 6, 2024
Issue 39 — Considerations for Nonclinical Dermal Studies: Advancing to Phase I
17 mins
Apr 2, 2024
Issue 38 — Optimal Preclinical Formulation and Drug Product Manufacture
24 mins
Language
English
Country
United States
Categories
Feed Host
Website
Feed
Request an Update
Updates may take a few minutes.